These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6684191)

  • 1. Biochemical aspects of experimental barbital dependence II: Effect on glycometabolism.
    Yanaura S; Kakuno K; Nakao K; Tagashira E
    Jpn J Pharmacol; 1983 Apr; 33(2):395-402. PubMed ID: 6684191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical aspects of experimental barbital dependence III: effect on neural energy reserve system.
    Yanaura S; Kakuno K; Nakao K; Matsukawa K; Urano T; Tagashira E
    J Toxicol Sci; 1982 May; 7(2):135-42. PubMed ID: 6890113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical aspects in the experimental barbital dependence IV--its effect on the hexokinase and phosphofructokinase activities in the rat brain.
    Yanaura S; Kakuno K; Nakao K
    J Toxicol Sci; 1983 May; 8(2):141-6. PubMed ID: 6225879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-Amino-7-phosphonoheptanoic acid, a selective antagonist of N-methyl-D-aspartate, prevents barbital withdrawal-induced convulsions and the elevation of cerebellar cyclic GMP in dependent rats.
    McCaslin PP; Morgan WW
    Neuropharmacology; 1987 Jul; 26(7A):731-5. PubMed ID: 2819762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased response of cerebellar cGMP to kainate but not NMDA or quisqualate following barbital withdrawal from dependent rats.
    McCaslin PP; Morgan WW
    Eur J Pharmacol; 1989 Dec; 173(2-3):127-32. PubMed ID: 2560429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation of physical dependence on barbiturates and cerebral monoamines.
    Tagashira E; Hiramori T; Urano T; Yanaura S
    Jpn J Pharmacol; 1983 Apr; 33(2):415-22. PubMed ID: 6193305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regionally selective metabolic effects of hypoglycemia in brain.
    Ratcheson RA; Blank AC; Ferrendelli JA
    J Neurochem; 1981 Jun; 36(6):1952-8. PubMed ID: 7017071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sex differences in the physical dependence on barbital in rats].
    Suzuki T; Koike Y; Yoshii T; Yanaura S
    Yakubutsu Seishin Kodo; 1986 Dec; 6(4):373-80. PubMed ID: 3825311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactate, 3-hydroxybutyrate, and glucose as substrates for the early postnatal rat brain.
    Dombrowski GJ; Swiatek KR; Chao KL
    Neurochem Res; 1989 Jul; 14(7):667-75. PubMed ID: 2779727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of tolerance to chronic barbital treatment in the cerebellar cyclic guanosine monophosphate system and its response to subsequent barbital abstinence.
    Lane SJ; Morgan WW
    J Pharmacol Exp Ther; 1985 Sep; 234(3):569-74. PubMed ID: 2993585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in glucose 1,6-bisphosphate content in rat skeletal muscle during contraction.
    Bassols AM; Carreras J; Cussó R
    Biochem J; 1986 Dec; 240(3):747-51. PubMed ID: 3827864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in brain levels of cyclic nucleotides and gamma-aminobutyric acid in barbiturate dependence and withdrawal.
    Lenox RH; Wray HL; Kant GJ; Hawkins TD; Meyerhoff JL
    Eur J Pharmacol; 1979 Apr; 55(2):159-69. PubMed ID: 222596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of synthesis inhibition on the levels of brain catecholamines in barbital-dependent rats.
    Morgan WW; Huffman RD; Pfeil KA; Gonzales EG
    Psychopharmacology (Berl); 1978 Jan; 56(1):41-4. PubMed ID: 415325
    [No Abstract]   [Full Text] [Related]  

  • 14. The effects of chronic oral administration of barbital on cerebellar cyclic GMP.
    Lane SJ; Morgan WW
    Neuropharmacology; 1984 Jul; 23(7A):779-83. PubMed ID: 6089024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catecholamine concentration in discrete brain areas following the withdrawal of barbital dependent rats.
    Morgan WW; Pfeil KA; Gonzales EG
    Life Sci; 1977 Feb; 20(3):493-9. PubMed ID: 557159
    [No Abstract]   [Full Text] [Related]  

  • 16. Regional distribution of barbital in the brain of mice during the development of tolerance and physical dependence.
    Lin SC; Sutherland VC
    Res Commun Chem Pathol Pharmacol; 1977 Oct; 18(2):215-31. PubMed ID: 562525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central nervous system supersensitivity and withdrawal from long-term treatment with barbital.
    Sandoval MR; Palermo-Neto J
    Neuropharmacology; 1985 Dec; 24(12):1247-51. PubMed ID: 4094660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of long-term forced oral barbital administration on endogenous acetylcholine in different regions of rat brain.
    Nordberg A; Wahlström G
    Eur J Pharmacol; 1977 Jun; 43(3):237-42. PubMed ID: 559577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Participant of serotonin turnover rate in the brain on barbital withdrawal convulsion.
    Tagashira E; Hiramori T; Urano T; Nakao K; Yanaura S
    Jpn J Pharmacol; 1982 Feb; 32(1):159-67. PubMed ID: 6177889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of propranolol on barbital dependence formation and withdrawal signs.
    Tagashira E; Hiramori T; Urano T; Nakao K; Yanaura S
    Jpn J Pharmacol; 1983 Feb; 33(1):133-43. PubMed ID: 6683767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.